Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Pathophysiology/Complications

Metabolic Alterations in Middle-Aged and Elderly Lean Patients With Type 2 Diabetes

  1. Graydon S. Meneilly, MD1 and
  2. Dariush Elahi, PHD2
  1. 1Division of Geriatric Medicine, the Department of Medicine, University of British Columbia, Vancouver, British Colombia, Canada
  2. 2Department of Surgery, University of Massachusetts Medical School, Worcester, Massachusetts
  1. Address correspondence and reprint requests to Graydon S. Meneilly, MD, Department of Medicine, Room 3300-950 West 10th Ave., Vancouver, BC, Canada, V5Z4E3. E-mail: meneilly{at}interchange.ubc.ca
Diabetes Care 2005 Jun; 28(6): 1498-1499. https://doi.org/10.2337/diacare.28.6.1498
PreviousNext
  • Article
  • Figures & Tables
  • Info & Metrics
  • PDF
Loading

Numerous studies (1–6) have systematically examined the metabolic alterations that occur in middle-aged patients with type 2 diabetes. These studies have found that when compared with age- and weight-matched control subjects, patients with type 2 diabetes have increased fasting hepatic glucose production, impaired glucose-induced release, and resistance to insulin-mediated glucose disposal. Diabetes is common in the elderly (7), but few studies (8–10) have examined the metabolic changes that occur in elderly subjects with diabetes. Recently, we compared metabolic changes in obese middle-aged and elderly control subjects and patients with diabetes (10). We now report our findings in lean middle-aged and elderly control subjects and patients with diabetes.

RESEARCH DESIGN AND METHODS

This study was conducted in middle-aged and elderly control subjects and patients with type 2 diabetes (Table 1). Control subjects and patients with diabetes were recruited as previously described (10). Data on 15 elderly control subjects and 10 elderly patients with diabetes has been published previously (9). Each subject underwent a glucose tolerance test, a hyperglycemic glucose clamp, and a euglycemic glucose clamp as previously described (10). Insulin and glucose values were measured as previously described (10). Students t test for unpaired samples was used for statistical analysis. Data are presented as means ± SE. P < 0.05 was considered significant.

RESULTS

Data are shown in Table 1. Hepatic glucose production was increased in middle-aged patients with diabetes relative to age-matched control subjects but was not elevated in elderly patients with type 2 diabetes. Glucose-induced insulin release was markedly impaired in both middle-aged and elderly patients with type 2 diabetes. Insulin-mediated glucose uptake was reduced by ∼20% in elderly patients with diabetes and by ∼50% in middle-aged patients with diabetes. This indicates a significantly greater degree of insulin resistance in middle-aged patients.

CONCLUSIONS

This study confirms our previous findings indicating that diabetes in the elderly is metabolically distinct (9,10). Lean elderly patients with diabetes have normal fasting hepatic glucose production, whereas glucose production is elevated in lean middle-aged patients with type 2 diabetes (1–3,5). The insulin responses to an oral and intravenous glucose challenge were reduced in both middle-aged and elderly lean patients with type 2 diabetes. Finally, while resistance to insulin-mediated glucose disposal is a manifestation of diabetes in both age-groups, the magnitude of the insulin resistance is substantially greater in middle-aged patients (1,3,4,6,8).

Taken together, the results of our studies suggest that diabetes in the elderly is metabolically distinct. In lean middle-aged patients with diabetes, it would seem appropriate to use combination therapy designed to target the multiple metabolic defects that are present. In lean elderly patients with type 2 diabetes, the initial approach should be directed toward enhancing insulin secretion or replacing the insulin deficit with exogenous insulin. This hypothesis must be tested in randomized controlled trials before it gains general acceptance.

View this table:
  • View inline
  • View popup
Table 1—

Demographic and metabolic data in patients and control subjects

Acknowledgments

This work was supported by a grant from the Canadian Diabetes Association. We gratefully acknowledge the support of the Allan McGavin Geriatric Endowment Fund of the University of British Columbia and the Jack Bell Geriatric Endowment Fund at Vancouver General Hospital.

We thank Rosemary Torressani, Eugene Mar, Christine Lockhart, and Gail Tedder for their assistance in conducting these studies. We are grateful to Linda Bloomfield for her assistance in the preparation of this manuscript. We are especially thankful to Dr. Kenneth L. Minaker for intellectual input in regard to these studies.

Footnotes

  • A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.

    • Accepted February 21, 2005.
    • Received February 17, 2005.
  • DIABETES CARE

References

  1. ↵
    Reaven G, Doberne L, Greenfield MS: Comparison of insulin secretion and in vivo insulin action in non obese and moderately obese individuals with NIDDM. Diabetes 31:382–384, 1982
    OpenUrlAbstract/FREE Full Text
  2. Defronzo RA, Bonnadonna RC, Ferrannini E: Pathogenesis of NIDDK: a balanced overview. Diabetes Care 15:318–368, 1992
    OpenUrlAbstract/FREE Full Text
  3. ↵
    Reaven G: Role of insulin resistance in human disease. Diabetes 37:1595–1607, 1988
    OpenUrlAbstract/FREE Full Text
  4. ↵
    Bonora E, Targher G, Alberiche M, Formentini G, Calcaterra F, Lombardi S, Marini F, Poli M, Zenari L, Raffaelli A, Perbelllini S, Zenere MB, Saggiani F, Bonadonna RC, Muggeo M: Predictors of insulin sensitivity in type 2 diabetes mellitus. Diabet Med 19:535–542, 2002
    OpenUrlCrossRefPubMedWeb of Science
  5. ↵
    Gastaldelli A, Baldi S, Pettiti M, Toschi E, Camastra S, Natali A, Landau BR, Ferrannini E: Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans. Diabetes 49:1367–1373, 2000
    OpenUrlAbstract
  6. ↵
    Nagasaka S, Tokuyama, Kusaka I, Hayashi H, Rokkaku K, Nakamura T, Kawakami A, Higashiyama M, Ishikawa S, Saito T: Endogenous glucose production and glucose effectiveness in type 2 diabetic subjects derived from stable labeled minimal model approach. Diabetes 48:1054–1060, 1999
    OpenUrlAbstract
  7. ↵
    Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, Wiedmeyer HM, Byrd-Holt DD: Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults: the Third National Health and Nutrition Examination Survey, 1988–1994. Diabetes Care21:518–524, 1998
  8. ↵
    Arner P, Pollare T, Lithell J: Different etiologies of type 2 diabetes in obese and non obese subjects. Diabetologia 34:483–487, 1991
    OpenUrlCrossRefPubMedWeb of Science
  9. ↵
    Meneilly GS, Elliott T, Tessier D, Hards L, Tildesley H: NIDDM in the elderly. Diabetes Care 19:1320–1325, 1996
    OpenUrlAbstract/FREE Full Text
  10. ↵
    Meneilly GS, Elliott T: Metabolic alterations in middle-aged and elderly obese patients with type 2 diabetes. Diabetes Care 22:112–118, 1999
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top
Diabetes Care: 28 (6)

In this Issue

June 2005, 28(6)
  • Table of Contents
  • About the Cover
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes Care.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Metabolic Alterations in Middle-Aged and Elderly Lean Patients With Type 2 Diabetes
(Your Name) has forwarded a page to you from Diabetes Care
(Your Name) thought you would like to see this page from the Diabetes Care web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Metabolic Alterations in Middle-Aged and Elderly Lean Patients With Type 2 Diabetes
Graydon S. Meneilly, Dariush Elahi
Diabetes Care Jun 2005, 28 (6) 1498-1499; DOI: 10.2337/diacare.28.6.1498

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Metabolic Alterations in Middle-Aged and Elderly Lean Patients With Type 2 Diabetes
Graydon S. Meneilly, Dariush Elahi
Diabetes Care Jun 2005, 28 (6) 1498-1499; DOI: 10.2337/diacare.28.6.1498
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • RESEARCH DESIGN AND METHODS
    • RESULTS
    • CONCLUSIONS
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Tables
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Insulin Resistance Is Associated With Enhanced Brain Glucose Uptake During Euglycemic Hyperinsulinemia: A Large-Scale PET Cohort
  • Restoration of Hypoglycemia Awareness Alters Brain Activity in Type 1 Diabetes
  • Processes Underlying Glycemic Deterioration in Type 2 Diabetes: An IMI DIRECT Study
Show more Pathophysiology/Complications

Similar Articles

Navigate

  • Current Issue
  • Standards of Care Guidelines
  • Online Ahead of Print
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.